Press "Enter" to skip to content


About Scott Rocklage

Dr. Scott Rocklage has been a Managing Member at 5 AM Venture Management Company since the year 2004. Scott Rocklage started working with 5 AM Ventures back in the year 2003 where he worked as a Venture Partner. In 11th May 2016 to 25th July the same year, Dr. Rocklage worked as the chief executive officer of EPIRUS Biopharmaceuticals Company where he also started as the acting President before he got the job permanently. In addition to that, he was also the President and Chief Executive Officer of Amersham Health.


Dr. Scott has so much experience in healthcare management that dates back to over 30 years ago with some essential leadership qualities in him. With this background, Scott Rocklage has led to the approval of some of the New Drug Applications in the United States which include Cubicin, Omniscan, and Teslascan by the Food and Drug Administration.


The Food and Drug Administration is an agency of the United States that has been mandated with the work of promoting and protecting the public health by supervising and controlling some of the drugs and products that are consumed by humans and even animals. Among other services that the Food and Drug Administration have been licensed with include regulating condoms, cellular phones, lasers and the control of diseases on some of the products that range from sperm donation, pets to assist in reproduction.


Dr. Scott Rocklage and his achievements in the medical sector do not stop at that as he has also been seen to put some drug candidates in trials in the clinical field. He has worked with some companies that are mainly focused on the health sector where he has brought his expertise. Some of these companies where he took different positions include Cubist Pharmaceuticals, Nycomed Salutar and he has also been a Board Chairman of Relypsa among the many firms that he has worked with.


Dr. Rocklage graduated with a Bachelor of Science degree in Chemistry from California University and went on to his Masters where graduated with a Ph.D. in Chemistry which he completed from Massachusetts Institute of Technology. He is based in Boston where he has an office.


About 5 AM Ventures

This is the number one venture capital firm that its goal is to build future generation science companies that can return profits to its investors. 5 AM ventures support any organization that seeks to solve different healthcare needs in the medical and science industry. The various companies by this firm look to prevent, diagnose and treat different medical conditions.


The professionals at the firm are experts who have a good knowledge of medical, scientific, operational and finance sector.


Visit to learn more.